Nimorazole
Sponsors
European Organisation for Research and Treatment of Cancer - EORTC, The Christie NHS Foundation Trust, Danish Head and Neck Cancer Group
Conditions
Gene Profile, Gene SignatureHead and Neck Squamous Cell CarcinomaHypoxiaHypoxic ModificationLocally Advanced Head and Neck HPV Negative Squamous Cell CancersRadiotherapy
Phase 3
AF CRT +/- Nimorazole in HNSCC
NCT01880359
Start: 2014-07-25End: 2023-01-09Target: 640Updated: 2022-05-10
NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
CompletedNCT01950689
Start: 2014-09-11End: 2021-01-07Updated: 2021-10-19
DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.
NCT02661152
Start: 2016-09-30End: 2023-12-31Target: 1252Updated: 2021-04-13